Restoring hope for terminal cancer patients – a 'St Jude' legacy by Bateman, Chris
IZINDABA
652       July 2016, Vol. 106, No. 7
Were it not for 80-year-old Prof. Ernette 
du Toit’s unceasing efforts to get South 
Africa (SA) and its donors on the global 
stem cell registry map, more than 100 
of her compatriots would not be alive 
and fulfilling their dreams and ambitions 
today.
The unique work, which requires exact 
donor matching to replace diseased bone 
marrow after a terminally ill prospective 
recipient has been subjected to lethal 
chemotherapy to destroy it, demands nerves 
of steel from all involved – especially those 
heading their country’s stem cell donor 
registry. Du Toit, who retired as Medical 
Director of the South African Bone Marrow 
Registry (SABMR) in April this year after 
a 25-year stint with the registry, was able 
to translate her early work in Groote 
Schuur Hospital’s Laboratory for Tissue 
Immunology (LTI) into a bone marrow 
registry that today has international life-
saving reach for patients suffering from 
certain end-stage haematological disorders. 
These include leukaemia, lymph node 
cancers, certain anaemias and SCIDS 
(severe combined immune deficiency syn-
drome, a rare genetic disorder in which 
affected children have no resistance to 
disease and must be kept isolated from 
infection after birth). Like many of life’s 
pivotal game-changers, she was, to use her 
own self-effacing description, ‘in the right 
place at the right time’ – and she grabbed 
the golden opportunity presented by her 
role in Prof. Chris Barnard’s first-ever heart 
transplant. In early December 1967, the LTI 
tissue-matched the heart donor for Louis 
Washkansky, who survived for 16 days, 
making history. 
Over the ensuing months and years, the 
LTI moved from matching tissue for hearts 
to kidneys and then livers, its staff in the 
process touring the world with Barnard, 
giving them direct access to the world’s 
top haematologists and immunologists. The 
late Prof. Peter Jacobs had in the meantime 
broken new immunological ground in SA 
with stem cell transplants, first in rabbits 
and later in humans. While the chance of a 
genetic match in family members – hugely 
reducing the chance of immunological 
transplant rejection – was as high as 25%, 
the net needed to be thrown far wider. The 
obvious next step was to set up a tissue typing 
registry – stimulated by feedback by Dutch 
haematologist Prof. Jon van Rood of the 
Haematology Department at the University 
of Leiden, who ran the Netherlands blood 
bank and co-ordinated the registration 
of unrelated potential stem cell donors 
worldwide. Explains du Toit: ‘Peter [Jacobs] 
said he’d do the transplant side and I was 
told by the international community [read 
Van Rood] that you cannot get donors from 
a global source unless you have a competent 
donor registry yourself – a kind of a quid pro 
quo and quality assurance set-up.’ She set to 
work to comply.
There are 76 bone marrow donor regis-
tries worldwide with 28 million registered 
donors, of whom just 71  000 are South 
Africans – the biggest ongoing issue being 
the tragically few black (global and local) 
donors and the gap between SA’s funded 
private transplant funding and unfunded 
state sector transplants. Add to this SA’s 
genetic diversity, in contrast to a more 
homogenous society like Japan, and you 
quickly realise how miraculous are the 
continued lives of the SA recipients, one 
now an around-the-world sailor and 
another, 5  years old at the time of the 
transplant, now a healthy teenager.
For over 70% of patients, their only hope 
is to find a donor via the SABMR, with the 
chances of finding a compatible unrelated 
donor standing at about one in 100 000.
The therapy itself, while risky because of 
the varying degrees of logistical complexity 
in the global donor cell retrieval (and ‘sell 
your house’ costly for the recipient and/or 
medical aid), has a 60 - 70% success rate, 
with 380 unrelated (i.e. non-family) bone 
marrow transplants conducted in SA since 
1991 after the SABMR was set up. 
All of which makes the reference to St 
Jude – patron saint of hope and impossible 
causes – so pertinent in Du Toit’s case. 
She says, with undiminished enthusiasm, 
‘It’s miraculous and magical what we can 
achieve. You’re actually destroying an 
individual’s whole immunological system 
and replacing it with one from somebody 
who’s like an identical twin, but found in 
the general population.’ Finding the donor 
is merely the first hurdle. The next is 
transporting the stem cells, mostly from 
overseas (Germany being a frequent go-to 
country, because of its efficiency and 
healthy registry), with European countries 
preferred because of the shorter travel time 
and a 72-hour stem cell expiry window. 
Du Toit tells stories of dedicated couriers 
(they carry a special cold-box at their 
feet, and even take it to the toilet with 
them) being delayed due to severe weather 
conditions, volcanic eruption clouds or 
technical flight hitches and having to catch 
a prebooked back-up flight, some arriving 
at the recipient’s bedside with just hours to 
spare. The drama and tension involved (the 
harvesting being done after the recipient’s 
immune system has already been destroyed 
several thousand kilometres away) are 
enough to give anyone grey hair. Du Toit, 
who speaks in strong, assertive but deeply 
empathic tones, reveals that international 
registry protocols prevent donors and reci-
pients from meeting for between 1 and 5 
years (SA is 5 years) after the transplant – 
for very good reasons. ‘You can’t afford for 
them to get emotionally involved. Bone 
marrow transplants are not infallible and 
the recipient might relapse, requiring a top-
up from the same donor or a full second 
transplant. If they met, the donor would not 
have the freedom to make an independent 
choice and consent a second time. We’ve 
had donors changing their minds. When it 
works, it’s actually one of the most amazing 
things that can happen between two people.’
This miraculous exchange happens some 
12  500 times a year worldwide, according 
to Terry Schlaphoff, deputy director of the 
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SABMR. Schlaphoff says that the setting up 
of the only internationally accredited tissue 
typing laboratory in Africa, introducing 
formal paternity testing in SA, hosting 
the World Marrow Donor Association 
conference in Cape Town in 2006 and 
helping discover a unique globally low-
frequency HLA antigen called A43 (a rare 
genetic marker found mainly in Khoisan 
people) will remain lasting strains in her 
former boss’s sonata. Asked about how 
she sees the future of stem cell transplants, 
Du Toit replies: ‘You don’t know today. I 
think stem cell transplant is probably pretty 
crude. There must be a development in the 
future where medication or some other 
intervention will be the answer. There’s 
hope somewhere in the future and stem cell 
registries may go out of fashion.’ She points 
to the ‘haplo’ transplants already taking 
place in SA, where recipients are ‘half-
identical’ to the donor, making it cheaper 
and easier to find a match.
Du Toit tried to take early retirement 
16  years ago (nobody could be found to 
replace her), and has just retired, with her 
medical doctor husband Len Anstey, to 
Century City outside Cape Town. It’s a far 
cry from her rural origins on a farm near 
Montagu, but she’s stayed a Capetonian, 
having graduated from the University of 
Cape Town in 1960, where Chris Barnard 
was one of her final-year lecturers. As a 
Groote Schuur house surgeon, she can 
remember his dedication in pitching up 
at a patient’s bedside at 3  a.m. ‘He’d look 
at the monitors, all normal, and then say, 
‘But the blood pressure’s going up!’ – he 
could work very intuitively, yet he also put 
together the first heart pumps. One day 
when the electricity went off he was able 
to instruct staff on how to keep it going 
manually,’ she said. Asked about Barnard’s 
reputation as a ladies’ man, she laughed. ‘I 
was always wary of getting too near him – 
he was not an easy man to work with, but 
I was fortunate in being a young woman 
(which softened his interactions).’ Now 
able to enjoy going to the theatre, indulge 
in some charity work and read – all things 
she seldom did ‘because I wanted to get 
up early to work’ – she sometimes drives 
her husband mad, indulging in her love 
for classical music and lieder (German 
music of the Romantic period with solo 
voice and piano accompaniment). It’s not 
that surprising; she counts one of the high 
points of her career as having performed 
the Alto Solo in Handel’s Messiah at the 
Cape Town City Hall during her early 
working career. 
Her ‘voice’, it seems, will linger on well 
beyond that historic hall.
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